Navigation Links
Israeli Innovation Shown to Demonstrate Reduction in Headaches and Neck Pain
Date:11/26/2012

TEL AVIV, Israel, November 26, 2012 /PRNewswire/ --

Israel-based medical device company  Headway medical  reports the successful completion of a series of clinical trials of Occiflex, its innovative therapeutic table designed to reduce chronic neck pain and headaches. The device will be available, starting in 2013, to physiotherapy clinics and rehabilitation centers throughout the world.

A revolutionary new device based on the principles of physiotherapy, Occiflex supports slow, repeated, and precise treatment for patients with muscle-dysfunction-related chronic pain. The Occiflex table mechanism allows physiotherapists to devise a manual mobilization file that is tailored to the needs of each patient, and, since it does not depend on the therapist's physical abilities, it can continue therapy for much longer than is standard and possible today. Plus, since each patient's therapy protocol is saved in a database, treatment can be reproduced precisely each time. The patient's file can be modified at any time, as conditions changes. The Occiflex treatment table improves the condition of the cervical joints, muscle, ligaments, and central nervous system control over the neck and head.

The Clinical Journal of Pain recently published a scientific article that describes the clinical trial conducted by Headway in the physiotherapy department of the Bnei Zion Medical Center in Haifa, Israel. The trial tested the advanced prototype developed by the company. Results indeed demonstrated a reduction of chronic neck pain in the patients and increased mobility.

According to Tamir Levital, CEO of Headway, "Occiflex will make the work of 50,000 physiotherapy and pain centers around the world more efficient and provide relief for the hundreds of millions who suffer from chronic neck pain and headaches. It will also save physiotherapists time and energy, and permit them to treat a number of patients simultaneously. The results of our trials show that Occiflex permits more precise, effective, repeated, and longer treatment than is possible today. We are very happy with the results of the trial and are getting ready to market Occiflex starting in 2013."

Headway, which got its start in the Misgav Venture Accelerator (owned by the Trendlines Group), was founded in 2006 by Dr. Yaron River, chief physician at the Neurology Department, Hillel Yaffe Medical Center, Hadera. The company has raised $1.5 million from private investors, the Misgav Venture Accelerator, and government R&D grants.

Media relations:
Efrat Kaduri
Ofir Shpigel Media and Public Relations
+972-4-9535030


'/>"/>
SOURCE Headway Medical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Fujifilm Spotlights DR Expansion, Innovation At RSNA 2012
2. Jury for 2012 Intercultural Innovation Award Announced
3. Le Dr Beau Lotto se joint aux grands penseurs à loccasion du débat sur linnovation 2012
4. Le professeur Brian Cox se joint aux grands penseurs à loccasion du débat sur linnovation 2012
5. Cutting-Edge German Medical Innovations Put Patients First
6. El profesor Brian Cox se une a los grandes pensadores en The Innovation Debate 2012
7. El doctor Beau Lotto se une a los grandes pensadores en The Innovation Debate 2012
8. MabVax Therapeutics Closes $5.25 Million Financing with Numoda Capital Innovations, Burrill Capital Fund IV, and RTP Venture Fund
9. CardioMEMS Named as a Finalist for Intel Innovation Award
10. Innovations in Ophthalmic Devices - Anterior Segment
11. Remedy Informatics Announces Growth Capital Investment from Merck Global Health Innovation Fund
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... environments  Oticon , industry leaders in ... the launch of Oticon Opn ™, the world,s ... world of possibilities for IoT devices.      ... Opn, Oticon introduces a number of ,world firsts,: ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... ... ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect Plugin ... whole new perspective by using the title layers in ProSlice Levels to split-up ... Levels contains over 30 Different presets to choose from. FCPX users can ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
Breaking Medicine News(10 mins):